Well the kicker is that the new combination becomes the new standard of care. so there's not much point developing generics which arent providing the best treatment.
Ann: Expanded Heart Protection Discovery for Zantrene, page-147
-
- There are more pages in this discussion • 240 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.91 |
Change
0.025(1.33%) |
Mkt cap ! $317.6M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.93 | $1.85 | $166.3K | 88.40K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2049 | $1.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.91 | 200 | 1 |
View Market Depth
| Last trade - 13.04pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |